Targeted Vitamin D Treatment of Schizophrenia-Associated Hyperprolinemia

NCT02197286 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Personnel changes at study site.

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Cholecalciferol
DRUG: Placebo

Sponsor

NYU Langone Health

Collaborators

[object Object]
[object Object]